NO933521L - Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-N-oksyder, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel - Google Patents
Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-N-oksyder, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddelInfo
- Publication number
- NO933521L NO933521L NO933521A NO933521A NO933521L NO 933521 L NO933521 L NO 933521L NO 933521 A NO933521 A NO 933521A NO 933521 A NO933521 A NO 933521A NO 933521 L NO933521 L NO 933521L
- Authority
- NO
- Norway
- Prior art keywords
- pyridine
- oxides
- carboxylic acid
- sulfonamidopyridine
- acylsulfonamido
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical class [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003176 fibrotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4233124A DE4233124A1 (de) | 1992-10-02 | 1992-10-02 | Acylsulfonamido- und Sulfonamidopyridin-2-carbonsäureester sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO933521D0 NO933521D0 (no) | 1993-10-01 |
| NO933521L true NO933521L (no) | 1994-04-05 |
| NO180085B NO180085B (no) | 1996-11-04 |
| NO180085C NO180085C (no) | 1997-02-12 |
Family
ID=6469456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO933521A NO180085C (no) | 1992-10-02 | 1993-10-01 | Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreestere og deres anvendelse som legemidler |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5428046A (no) |
| EP (1) | EP0590520B1 (no) |
| JP (1) | JPH06211795A (no) |
| KR (1) | KR940009156A (no) |
| CN (1) | CN1089603A (no) |
| AT (1) | ATE139227T1 (no) |
| AU (1) | AU662448B2 (no) |
| CA (1) | CA2107514A1 (no) |
| CZ (1) | CZ283869B6 (no) |
| DE (2) | DE4233124A1 (no) |
| DK (1) | DK0590520T3 (no) |
| ES (1) | ES2090806T3 (no) |
| FI (1) | FI103881B (no) |
| GR (1) | GR3020230T3 (no) |
| HK (1) | HK1006713A1 (no) |
| HU (1) | HUT67292A (no) |
| IL (1) | IL107155A (no) |
| MY (1) | MY110277A (no) |
| NO (1) | NO180085C (no) |
| NZ (1) | NZ248819A (no) |
| PH (1) | PH30677A (no) |
| PL (1) | PL176772B1 (no) |
| RU (1) | RU2117660C1 (no) |
| TW (1) | TW258733B (no) |
| ZA (1) | ZA937298B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL135495A (en) * | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
| DE19742951A1 (de) * | 1997-09-29 | 1999-04-15 | Hoechst Schering Agrevo Gmbh | Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung |
| DE19746287A1 (de) * | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
| DE3703963A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE3703962A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE3707429A1 (de) * | 1987-03-07 | 1988-09-15 | Hoechst Ag | Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
| DE4031000A1 (de) * | 1990-10-01 | 1992-04-09 | Hoechst Ag | 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel |
-
1992
- 1992-10-02 DE DE4233124A patent/DE4233124A1/de not_active Withdrawn
-
1993
- 1993-08-05 TW TW082106253A patent/TW258733B/zh active
- 1993-09-22 US US08/124,683 patent/US5428046A/en not_active Expired - Fee Related
- 1993-09-23 ES ES93115361T patent/ES2090806T3/es not_active Expired - Lifetime
- 1993-09-23 DE DE59302898T patent/DE59302898D1/de not_active Expired - Fee Related
- 1993-09-23 EP EP93115361A patent/EP0590520B1/de not_active Expired - Lifetime
- 1993-09-23 AT AT93115361T patent/ATE139227T1/de not_active IP Right Cessation
- 1993-09-23 DK DK93115361.3T patent/DK0590520T3/da active
- 1993-09-29 IL IL10715593A patent/IL107155A/en not_active IP Right Cessation
- 1993-09-29 CN CN93118248A patent/CN1089603A/zh active Pending
- 1993-09-30 PH PH46989A patent/PH30677A/en unknown
- 1993-09-30 MY MYPI93001990A patent/MY110277A/en unknown
- 1993-09-30 FI FI934303A patent/FI103881B/fi active
- 1993-09-30 CZ CZ932044A patent/CZ283869B6/cs not_active IP Right Cessation
- 1993-09-30 NZ NZ248819A patent/NZ248819A/en unknown
- 1993-10-01 HU HU9302778A patent/HUT67292A/hu unknown
- 1993-10-01 CA CA002107514A patent/CA2107514A1/en not_active Abandoned
- 1993-10-01 PL PL93300561A patent/PL176772B1/pl unknown
- 1993-10-01 NO NO933521A patent/NO180085C/no not_active IP Right Cessation
- 1993-10-01 ZA ZA937298A patent/ZA937298B/xx unknown
- 1993-10-01 RU RU93056156A patent/RU2117660C1/ru active
- 1993-10-01 AU AU48726/93A patent/AU662448B2/en not_active Ceased
- 1993-10-02 KR KR1019930020299A patent/KR940009156A/ko active IP Right Grant
- 1993-10-04 JP JP5247717A patent/JPH06211795A/ja active Pending
-
1996
- 1996-06-13 GR GR960401603T patent/GR3020230T3/el unknown
-
1998
- 1998-06-22 HK HK98105875A patent/HK1006713A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO941677L (no) | Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel | |
| FI883249A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi | |
| DK0624595T3 (da) | Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler | |
| CA2039197A1 (en) | Pharmaceutic Formulation for the Treatment of Alcoholism | |
| DK0495982T3 (da) | Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel | |
| AU1331588A (en) | Method for treatment of alcohol abuse | |
| NO178398C (no) | Piperidin derivater og farmasöytisk formulering | |
| DK515489D0 (da) | Dispergerbar laegemiddelformulering | |
| KR0148213B1 (en) | Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same | |
| IL90056A (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
| NO881308L (no) | Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler. | |
| NO301767B1 (no) | Salt av clavulansyre | |
| NO933521L (no) | Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-N-oksyder, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel | |
| DK119188D0 (da) | Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne | |
| DK0388298T3 (da) | Azetidinylsubstituerede derivater af pyridoncarboxylsyrer, deres fremstilling og anvendelse som lægemidler | |
| DK284588A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler. | |
| FR2692262B1 (fr) | Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| DK47988D0 (da) | Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter | |
| NO166788C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner. | |
| WO1995022544A3 (de) | Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika | |
| NO933199L (no) | Heteroarenylpiperaziner, fremgangsmåte for deres fremstilling og anvendelse derav som legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2002 |